Your browser doesn't support javascript.
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Añadir filtros

Base de datos
Tipo del documento
Intervalo de año
1.
Antiviral Res ; 208: 105451, 2022 Dec.
Artículo en Inglés | MEDLINE | ID: covidwho-2085917

RESUMEN

A recent study demonstrated that a DNA-RNA dual-activity topoisomerase complex, TOP3B-TDRD3, is required for normal replication of positive-sense RNA viruses, including several human flaviviruses and coronaviruses; and the authors proposed that TOP3B is a target of antiviral drugs. Here we examined this hypothesis by investigating whether inactivation of Top3b can inhibit the replication of a mouse coronavirus, MHV, using cell lines and mice that are inactivated of Top3b or Tdrd3. We found that Top3b-KO or Tdrd3-KO cell lines generated by different CRISPR-CAS9 guide RNAs have variable effects on MHV replication. In addition, we did not find significant changes of MHV replication in brains or lungs in Top3B-KO mice. Moreover, immunostaining showed that Top3b proteins are not co-localized with MHV replication complexes but rather, localized in stress granules in the MHV-infected cells. Our results suggest that Top3b does not have a universal role in promoting replication of positive-sense RNA virus, and cautions should be taken when targeting it to develop anti-viral drugs.


Asunto(s)
Infecciones por Coronavirus , Coronavirus , Virus de la Hepatitis Murina , Virus ARN , Animales , Ratones , Antivirales/farmacología , Línea Celular , Coronavirus/genética , Infecciones por Coronavirus/tratamiento farmacológico , Virus de la Hepatitis Murina/genética , Virus de la Hepatitis Murina/metabolismo , Proteínas , ARN Viral/genética , ARN Viral/metabolismo , Replicación Viral
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA